Concord Drugs Ltd

Concord Drugs Ltd

₹ 37.3 1.11%
26 Apr 1:09 p.m.
About

Incorporated in 1995, Concord Drugs Ltd manufactures licensed drugs based on
approved formulations

Key Points

Product Portfolio:[1]
a) Pharmaceutical Ready to fill Pellets
b) Multiple Unit Pellet System (MUPS)
c) Tissue Bio Adhesive
d) Injectables (Small Volume Parenterals)
e) Oral Solid Dosages (Tablets & Capsules)
f) Liquid Orals (Syrups & Suspensions)
g) Dry Syrup (Powder)

  • Market Cap 37.3 Cr.
  • Current Price 37.3
  • High / Low 61.5 / 25.6
  • Stock P/E 43.9
  • Book Value 33.2
  • Dividend Yield 0.00 %
  • ROCE 6.01 %
  • ROE 2.99 %
  • Face Value 10.0

Pros

  • Stock is trading at 1.11 times its book value
  • Promoter holding has increased by 3.28% over last quarter.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -0.19% over past five years.
  • Company has a low return on equity of 3.49% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
8.24 8.35 20.22 9.83 13.44 15.46 12.53 13.72 13.53 11.54 8.79 7.38 12.62
7.59 7.63 17.95 8.19 12.42 14.80 11.56 12.53 12.08 10.80 7.39 5.85 12.06
Operating Profit 0.65 0.72 2.27 1.64 1.02 0.66 0.97 1.19 1.45 0.74 1.40 1.53 0.56
OPM % 7.89% 8.62% 11.23% 16.68% 7.59% 4.27% 7.74% 8.67% 10.72% 6.41% 15.93% 20.73% 4.44%
3.53 0.26 0.02 0.03 0.03 0.02 0.01 0.00 0.00 0.00 0.00 0.01 0.00
Interest 0.22 0.27 0.96 0.31 0.18 0.23 0.34 0.42 0.45 0.42 0.39 0.39 0.43
Depreciation 0.39 0.33 0.53 0.57 0.30 0.37 0.39 0.53 0.38 0.31 0.38 0.38 0.38
Profit before tax 3.57 0.38 0.80 0.79 0.57 0.08 0.25 0.24 0.62 0.01 0.63 0.77 -0.25
Tax % 24.65% 10.53% 15.00% 43.04% 28.07% 62.50% 28.00% 25.00% 25.81% -600.00% 23.81% 31.17% 4.00%
2.70 0.34 0.69 0.46 0.42 0.03 0.19 0.18 0.45 0.07 0.49 0.53 -0.24
EPS in Rs 3.09 0.39 0.79 0.53 0.48 0.03 0.22 0.21 0.51 0.08 0.53 0.57 -0.24
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
27.66 28.07 33.95 40.02 50.68 57.43 51.80 48.08 51.34 51.33 58.96 51.31 40.33
24.52 25.75 30.72 32.99 42.38 51.93 47.02 44.43 48.00 48.11 53.37 46.97 36.10
Operating Profit 3.14 2.32 3.23 7.03 8.30 5.50 4.78 3.65 3.34 3.22 5.59 4.34 4.23
OPM % 11.35% 8.27% 9.51% 17.57% 16.38% 9.58% 9.23% 7.59% 6.51% 6.27% 9.48% 8.46% 10.49%
0.03 0.00 0.12 0.37 0.15 0.09 0.14 0.09 0.12 3.86 0.10 0.01 0.01
Interest 0.39 0.52 1.78 2.72 2.57 2.36 1.88 1.59 1.54 1.42 1.68 1.62 1.63
Depreciation 0.60 0.72 1.14 3.63 2.91 2.58 2.40 1.71 1.46 1.37 1.76 1.60 1.45
Profit before tax 2.18 1.08 0.43 1.05 2.97 0.65 0.64 0.44 0.46 4.29 2.25 1.13 1.16
Tax % 27.06% 3.70% 20.93% 33.33% 40.74% 73.85% 50.00% 9.09% 28.26% 23.54% 28.89% 21.24%
1.59 1.04 0.34 0.70 1.75 0.16 0.32 0.41 0.33 3.28 1.59 0.89 0.85
EPS in Rs 2.19 1.44 0.47 0.97 2.42 0.22 0.41 0.52 0.38 3.75 1.82 0.96 0.94
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 6%
5 Years: 0%
3 Years: 0%
TTM: -27%
Compounded Profit Growth
10 Years: -2%
5 Years: 23%
3 Years: 39%
TTM: -44%
Stock Price CAGR
10 Years: %
5 Years: 10%
3 Years: 0%
1 Year: 27%
Return on Equity
10 Years: 3%
5 Years: 3%
3 Years: 3%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 7.24 7.24 7.24 7.24 7.24 7.24 7.86 7.86 8.74 8.74 8.74 9.32 9.32
Reserves 5.57 6.99 7.33 6.07 7.82 11.75 11.46 15.29 14.74 18.02 19.62 21.83 23.83
7.98 15.70 17.31 21.27 19.99 15.43 13.62 9.83 9.57 12.97 16.43 15.63 15.46
9.21 11.20 12.80 19.63 17.44 21.11 73.48 49.79 24.96 10.15 11.66 9.86 8.30
Total Liabilities 30.00 41.13 44.68 54.21 52.49 55.53 106.42 82.77 58.01 49.88 56.45 56.64 56.91
4.79 5.48 20.84 18.32 15.18 13.64 13.51 11.85 10.52 13.83 13.97 12.86 12.11
CWIP 3.37 13.84 0.00 0.00 0.00 0.00 0.00 0.29 1.00 0.00 0.55 0.92 1.09
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.42 1.42
21.84 21.81 23.84 35.89 37.31 41.89 92.91 70.63 46.49 36.05 41.93 41.44 42.29
Total Assets 30.00 41.13 44.68 54.21 52.49 55.53 106.42 82.77 58.01 49.88 56.45 56.64 56.91

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-3.21 1.18 2.28 1.75 3.05 1.70 6.88 1.19 2.48 1.62 0.77 2.24
-2.44 -9.65 -2.14 -1.10 0.23 -1.04 -2.21 -0.34 -0.84 -3.67 -2.44 -2.27
6.14 7.63 -0.17 -0.70 -3.42 -3.94 -4.80 -0.73 -1.79 2.07 1.68 0.05
Net Cash Flow 0.49 -0.84 -0.03 -0.06 -0.14 -3.28 -0.13 0.12 -0.15 0.02 0.01 0.03

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 191.74 205.06 180.83 249.90 183.51 99.46 501.49 367.66 180.94 147.41 141.52 116.31
Inventory Days 43.27 55.54 65.28 65.82 76.39 87.31 156.96 171.81 140.84 100.83 151.64 156.25
Days Payable 124.22 144.69 140.64 207.64 92.05 129.50 559.47 393.02 109.72 26.76 62.25 45.98
Cash Conversion Cycle 110.79 115.91 105.47 108.09 167.85 57.27 98.98 146.44 212.05 221.48 230.90 226.58
Working Capital Days 108.87 126.52 116.00 146.84 169.18 62.86 142.76 171.72 165.15 205.86 198.84 243.14
ROCE % 15.18% 6.31% 7.15% 11.35% 16.06% 8.67% 7.48% 6.16% 6.06% 5.36% 9.30% 6.01%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
49.00% 49.00% 49.00% 49.00% 49.00% 49.00% 49.00% 52.13% 52.13% 52.13% 55.41% 55.41%
51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 47.87% 47.87% 47.87% 44.59% 44.60%
No. of Shareholders 2,8262,8263,0713,0473,0363,1883,3213,2043,1983,9574,0324,734

Documents